Filing Details

Accession Number:
0001225208-21-011502
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-16 20:12:45
Reporting Period:
2021-08-13
Accepted Time:
2021-08-16 20:12:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805617 B. Jennifer Damico Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Svp & Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-13 1 $48.29 11,429 No 4 S Direct
Common Stock Disposition 2021-08-13 1,660 $48.30 9,769 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock Units SSP Acquisiton 2021-08-13 25 $48.48 25 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,818 No 4 A Direct
Footnotes
  1. Each unit represents one phantom share of common stock.
  2. These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.